Pictet Asset Management (Switzerland)’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$36.4M Buy
2023
Q1
$5.89M Buy
2022
Q4
$2.81M Sell
2022
Q3
$38.2M Buy
2022
Q2
$40.1M Buy
2022
Q1
$43M Buy
2021
Q4
$42.2M Buy
2021
Q3
$24.6M Buy